152 related articles for article (PubMed ID: 29199659)
61. Induction chemotherapy with cisplatin and ifosfamide in locally advanced inoperable squamous cell carcinoma of the head and neck: A single-institution experience.
Zaheer S; Siddiqui SA; Akram M; Hasan SA
Indian J Cancer; 2016; 53(3):372-376. PubMed ID: 28244461
[TBL] [Abstract][Full Text] [Related]
62. [Combination of induction chemotherapy with surgery and/or radiotherapy in locally advanced head and neck cancers. A retrospective analysis of a series of 125 patients].
Ray-Coquard I; Bolla M; Reyt E; Brochon D; Lebeau J; Colonna M; Kolodié H; Vincent F; Chinal-Provencal J
Bull Cancer; 1997 Sep; 84(9):863-8. PubMed ID: 9435807
[TBL] [Abstract][Full Text] [Related]
63. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
[TBL] [Abstract][Full Text] [Related]
64. A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN).
Grover S; Mitra N; Wan F; Lukens JN; Sharma S; Bauman J; Masroor F; Cohen RB; Desai A; Algazy K; Alonso-Basanta M; Ahn P; Kevin Teo BK; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Am J Clin Oncol; 2016 Oct; 39(5):522-7. PubMed ID: 27441910
[TBL] [Abstract][Full Text] [Related]
65. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
[No Abstract] [Full Text] [Related]
66. Carboplatin-based concurrent chemoradiation therapy in locally advanced head and neck cancer patients who are unfit for cisplatin therapy.
Noronha V; Sharma V; Joshi A; Patil VM; Laskar SG; Prabhash K
Indian J Cancer; 2017; 54(2):453-457. PubMed ID: 29469077
[TBL] [Abstract][Full Text] [Related]
67. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
68. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
69. Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.
Nicolau UR; de Jesus VHF; Lima ENP; Alves MS; de Oliveira TB; Andrade LB; Silva VS; Bes PC; de Paiva TF; Calsavara VF; Guimarães APG; Cezana L; Barbosa PNVP; Porto GCLM; Pellizzon ACA; de Carvalho GB; Kowalski LP
PLoS One; 2018; 13(8):e0200823. PubMed ID: 30114190
[TBL] [Abstract][Full Text] [Related]
70. Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses.
Brandão TB; Morais-Faria K; Ribeiro ACP; Rivera C; Salvajoli JV; Lopes MA; Epstein JB; Arany PR; de Castro G; Migliorati CA; Santos-Silva AR
Support Care Cancer; 2018 Jul; 26(7):2417-2423. PubMed ID: 29423682
[TBL] [Abstract][Full Text] [Related]
71. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
72. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
73. Pathology of advanced buccal mucosa cancer involving masticator space (T4b).
Trivedi NP; Kekatpure VD; Shetkar G; Gangoli A; Kuriakose MA
Indian J Cancer; 2015; 52(4):611-5. PubMed ID: 26960493
[TBL] [Abstract][Full Text] [Related]
74. Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortium.
Hainsworth JD; Spigel DR; Greco FA; Shipley DL; Peyton J; Rubin M; Stipanov M; Meluch A
Cancer J; 2011; 17(5):267-72. PubMed ID: 21952273
[TBL] [Abstract][Full Text] [Related]
75. Is taxane/platinum/5 fluorouracil superior to taxane/platinum alone and does docetaxel trump paclitaxel in induction therapy for locally advanced oral cavity cancers?
Noronha V; Patil V; Joshi A; Muddu V; Bhattacharjee A; Juvekar S; Arya S; Chaturvedi P; Chaukar D; Pai PS; Dcruz AK; Prabhash K
Indian J Cancer; 2015; 52(1):70-3. PubMed ID: 26837979
[TBL] [Abstract][Full Text] [Related]
76. Survival and clinicopathological characteristics of cT4b oral squamous cell carcinoma based on different treatment modalities: A single-center retrospective study.
Lin NC; Hsu JT; Chen MYC; Tsai KY
Medicine (Baltimore); 2022 May; 101(19):e29285. PubMed ID: 35583539
[TBL] [Abstract][Full Text] [Related]
77. Neoadjuvant immunoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma: a retrospective study.
Shen P; Qiao B; Jin N; Wang S
Invest New Drugs; 2022 Dec; 40(6):1282-1289. PubMed ID: 35972629
[TBL] [Abstract][Full Text] [Related]
78. 'T4b' or not to 'T4b': addressing the resectability in T4b oral cavity squamous cell carcinoma.
Joy A; Subash A; Thakur S; Rao V
Int J Oral Maxillofac Surg; 2022 Dec; 51(12):1605-1606. PubMed ID: 35599081
[No Abstract] [Full Text] [Related]
79. Chemotherapy for primary cancer can reduce the risk of head and neck second primary malignancy: a propensity-matched analysis.
Xiong L; Yu H; Wei W; Wang C; Li B; Liu H; Cheng A; Li D; Han Z; Feng Z
Clin Oral Investig; 2023 Feb; 27(2):571-580. PubMed ID: 36239788
[TBL] [Abstract][Full Text] [Related]
80. Reply to the Letter to the Editor "'T4b' or not to 'T4b': addressing the resectability in T4b oral cavity squamous cell carcinoma".
Thavarool SB; Narendra AK
Int J Oral Maxillofac Surg; 2022 Dec; 51(12):1606. PubMed ID: 35534322
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]